Investigational drug · Phase 3
Debio 4126
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acromegaly.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "Debio 4126"
First trial start
2025
Nov 26, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Debio 4126", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acromegaly
Approved drugs for the same conditions: Acromegaly · Endocrinology and women's health
Largest trials
Live from ClinicalTrials.gov: studies naming "Debio 4126" as an intervention, largest first.
- A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin AnalogsPivotal-lookingRecruiting
Debiopharm International SAIndustry
NCT06930625 · 119 participants (planned) · Start Nov 26, 2025 · Primary completion Jun 2028
Drug: Debio 4126; Placebo · For: Acromegaly
Sites: Los Angeles, California; Chicago, Illinois; Boston, Massachusetts · 74 sites in all
Debiopharm International SAIndustry
NCT05364944 · 19 participants · Start May 18, 2022 · Primary completion Oct 29, 2024
Drug: Debio 4126; Sandostatin LAR and 1 more · For: Acromegaly; GEP-NET
Sites: Copenhagen, Denmark; Angers, France; Le Kremlin-Bicêtre, France · 14 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- What is the future of acromegaly therapy?
Schilbach K, Strasburger CJ · J Clin Endocrinol Metab 2026
Also in development for Acromegaly
- CAM2029octreotide depotPhase 33 trials
Camurus AB · Polycystic Liver Disease, Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly
- SYHX2008Phase 33 trials
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Diagnosed With Acromegaly, Currently in the Active Stage of the Disease, Gastrointestinal Neuroendocrine Pancreatic Tumor, Acromegaly
- MAR002Phase 21 trial
Marea Therapeutics · Acromegaly
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.